摘要：

Ledipasvir (LED) and Sofosbuvir (SOF) are newly approved antiviral agents co-formulated for treatment of hepatitis C virus. In the present work; an accurate and precise TLC densitometric method has been developed for simultaneous determination of LED and SOF in their bulk and dosage form. The proposed method based on determination of the UV-visualized bands after TLC separation of LED and SOF....

展开